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Abstract Transformation of NIH 3T3 fibroblasts by Ha-Ras 
resulted in large increases in the phosphorylation of both 
[14Clethanolamine (Etn) and [~4Clcholine (Cho) when these pre- 
cursors were added to the medium. Wortmannin, an inhibitor of 
phosphatidylinositol 3-kinase (PI3K), preferentially decreased 
pbosphorylation of externally added Etn in the Ha-Ras trans- 
formed, hut not in the nntransformed, fibroblasts. However, wort- 
mannin had no effect on the pbosphorylation of Etn formed 
endogenously by phorbol ester-stimulated hydrolysis of phosphat- 
idylethanolamine. Data suggest hat interaction of mutated Ras 
with PI3K leads to specific stimulation of Etn uptake, followed 
by nearly quantitative phosphorylation of Etn by a Ras-activated 
Cho/Etn kinase. 
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I. Introduction 
Ras genes encode proteins which regulate key signaling path- 
ways involved in cell growth and development [1-5]. One of the 
many actions of  activated Ras is stimulation of expression/ 
activity of choline (Cho) kinase [6]. In view of a recent report 
[7] demonstrating that choline phosphate (ChoP) is a positive 
regulator of cell growth, stimulation of Cho kinase activity by 
activated (oncogenic) Ras may be required for the rapid growth 
of transformed cells. 
We have recently reported [8] that the environmental carcin- 
ogens benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene en- 
hanced both the formation of ethanolamine (Etn) from 
phosphatidylethanolamine (PtdEtn) and subsequent phospho- 
rylation of Etn to Etn phosphate (EtnP). Since the transforming 
activity of carcinogens may involve activation of Ras [9-12], 
and because in most cases Cho kinase also phosphorylates Etn, 
it seemed likely that activated Ras, such as present in Ha-Ras- 
transformed fibroblasts, will also phosphorylate Etn to a 
greater extent. The major goal of this work was to examine this 
possibility. 
Phosphatidylinositol 3-kinase (PI3K) has recently been 
found to be a direct target of Ras [13]. This prompted us to 
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examine the possible role of PI3K in the mediation of Ras 
effects on Cho/Etn kinase activity. Since wortmannin has been 
reported to be a specific potent inhibitor of PI3K [14], the 
possible effects of this drug on the phosphorylation of Etn and 
Cho in untransformed and Ha-Ras-transformed NIH 3T3 fi- 
broblasts were also determined. 
2. Experimental 
2.1. Materials 
Wortmannin, phorbol 12-myristate 13-acetate (PMA), Etn, Cho and 
Dowex-50W[H ÷ form] were purchased from Sigma; [2-~4C]ethanolam- 
ine (55 mCi/mmol) and [methyl-~4C]choline (50 mCi/mmol) were 
bought from Amersham; tissue culture reagents were from Gibco-BRL. 
2.2. Cell culture 
NIH 3T3 clone 7 fibroblasts transfected with Harvey-murine-sar- 
coma virus [15] as well as the parent cell line were obtained from Dr. 
Douglas R. Lowy (National Cancer Institute, Bethesda, MD, USA). 
Cells were cultured continuously in Dulbecco's modified Eagle's me- 
dium supplemented with 10% (v/v) fetal-calf serum, penicillin/strepto- 
mycin (50 units/ml and 50/.tg/ml, respectively) and glutamine (2 mM). 
2.3. Determination of cellular uptake and phosphorylation of [14 C]Etn 
and [14C]Cho in fibroblasts 
Fibroblasts were grown in 12-well tissue culture dishes to confluency 
and then incubated in the presence of wortmannin (50-200 nM) for 
1 h. This was followed (with no washing step being included) by incuba- 
tions of fibroblasts for 30-150 min in the presence of 50/2M [14C]Etn 
(955,000 dpm/well) or 50pM [~4C]Cho (1.21 × 106 dpm/well). At the end 
of incubations, the incubation medium was aspirated, then fibroblasts 
were gently, but rapidly (within 20 s), washed with 5 ml medium fol- 
lowed by the addition of ice-cold methanol (2 ml) to the wells. Then, 
cells were scraped into methanol, and methanol extracts were rapidly 
transferred to 2 ml of chloroform. The water-soluble metabolites of 
[14C]Etn and [14C]Cho were fractionated on Dowex-50W[H*]-packed 
columns (Bio-Rad Econo columns, 1 ml bed volume) as described by 
Cook and Wakelam [16], with the following modifications. The initial 
flow-through (4.5 ml) along with a following 3.5- or 5-ml water wash 
contained glycerophosphoethanolamine or glycerophosphocholine, re- 
spectively. EtnP and ChoP were eluted by 15 and 20 ml water, respec- 
tively. Finally, Etn and Cho were eluted by 12 and 20 ml of 1 M HCI, 
respectively. The metabolites of [14C]Etn and [14C]Cho were identified 
and phospholipids were separated as indicated previously [17]. 
2.4. Determination of Etn and EtnP formation by phospholipase- 
mediated hydrolysis of PtdEtn in fibroblasts 
Ha-Ras-transformed and untransformed fibroblasts were grown as 
above to near confluency in the presence of [~4C]Etn (1/.tCi/well; 48 h 
incubation). Fibroblasts were washed and then incubated in fresh me- 
dium for 4 h to achieve acceptable background levels of [~4C]Etn (210- 
250 dprn/well) and [~4C]EtnP (1030-1140 dpm/well); wortmannin was 
added for the last 1 h of the 4-h incubation period. At this point, only 
PtdEtn was significantly labeled (305,000-322,000 dpm/well). This step 
was followed by treatment of fibroblasts (in the continuous presence 
of wortmannin, when appropriate) for 2 h with 100 nM PMA in the 
presence of 50/2M or 1 mM unlabeled Etn. Formation of water-soluble 
products of [~4C]PtdEtn hydrolysis was determined as above, except 
that the incubation medium was not removed before the addition of 
ice-cold methanol. 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  00 1 4-5793 (94)0 1 37 1-3 
280 Z. Kiss, KS. Crilly/FEBS Letters 357 (1995) 279-282 
3. Resu l t s  and  d i scuss ion  
In different species, Etn has been shown to exist in the circu- 
lation at concentrations ranging from 5 to 50 pM (referenced 
in [18]). Therefore, to ensure that these results will be relevant 
to physiological conditions, in most experiments he concentra- 
tion of externally added [~4C]Etn was 50//M. When confluent 
untransformed (Fig. 1A) and Ras-transformed (Fig. 1B) fi- 
broblasts were incubated in the presence of [14C]Etn, the in- 
crease in the cellular content of [~4C]Etn in both cases reached 
a plateau after 120-150 min incubation. However, at each time 
point examined, Ha-Ras transformed cells accumulated some- 
what more [~4C]Etn consistent with stimulation of the uptake 
mechanism. At 50 and 200 nM concentrations wortmannin 
slightly enhanced the cellular content of [~4C]Etn in both cell 
lines. At each time interval examined (30-150 min), the rate of 
[~4C]EtnP formation was 13- to 16-fold greater in the Ras- 
transformed cells (Fig. 1D) than in the untransformed cells 
(Fig. 1C). While in the control cells wortmannin had no effect 
on the formation of [~4C]EtnP, in the Ras-transformed cells 50 
and 200 nM concentrations ofwortmannin decreased phospho- 
rylation of Etn by 16 to 37% at various time points. At 200 nM 
concentration wortmannin was slightly more effective than at 
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Fig. 1. Uptake and metabolism of [~4C]Etn in untransformed and Ha- 
Ras-transformed NIH 3T3 fibroblasts. Untransformed (A,C,E) and 
Ras-transformed (B,D,F) fibroblasts, grown in 12-well culture dishes 
up to confluency, were untreated (e), or were treated with 50 nM (A) 
or 200 nM (1) wortmannin for 1 h. At this time point, each well received 
(without removing wortmannin) [14C]Etn, as described in section 2, and 
incubations continued for up to 150 min. Incorporation of exogenous 
[~4C]Etn into the cellular pool of [J4C]Etn (A,B), [14C]EtnP (C,D) and 
[~4C]PtdEtn (E,F) was determined as described in section 2. Each point 
represents he mean + S.E.M. of six independent incubations. At each 
time point examined, the inhibitory effects of 50-200 nM wortmannin 
were statistically significant (P < 0.05~).01) by Student's t-test. Similar 
results were obtained in another experiment performed in triplicate. 
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Fig. 2. Uptake and metabolism of [14C]Cho in untransformed and 
Ha-Ras-transformed NIH 3T3 fibroblasts. Untransformed (A,C,E) 
and Ras-transformed (B,D,F) fibroblasts, grown in 12-well culture 
dishes up to confluency, were untreated (e), or were treated with 50 nM 
(A) or 200 nM (1) wortmannin for 1 h. At this time point, each well 
received (without removing wortmannin) [t4C]Cho, as described in sec- 
tion 2, and incubations continued for up to 150 min. Incorporation of 
exogenous [IaC]Cho into the cellular pool of [14C]Cho (A,B), [~4C]ChoP 
(C,D) and [~4C]PtdCho (E,F) was determined as described in section 2. 
Each point represents he mean + S.E.M. of eight independent incuba- 
tions. In some cases, the effect of 50 nM wortmannin isnot shown; this 
is to avoid confusion because 50 nM and 200 nM concentrations caused 
practically the same effect. *P (P < 0.05) different from the respective 
control value (Student's t-test). 
50 nM concentration, while at both concentrations its inhib- 
itory effects did not appear to significantly depend on the length 
of incubation time. 
Stimulation of [~4C]EtnP formation in the Ras-transformed 
cells was reflected in a much higher rate of [~4C]PtdEtn forma- 
tion (Fig. 1F) compared to untransformed cells (Fig. 1E). Sim- 
ilarly, wortmannin decreased J4C-labeling of PtdEtn only in the 
Ras-transformed cells (Fig. 1F), but not in the untransformed 
cells (Fig. 1E). 
Accumulation of [14C]Cho by confluent cultures of untrans- 
formed (Fig. 2A) and Ras-transformed cells (Fig. 2B) similarly 
reached a plateau after 120 min incubation. Ha-Ras-trans- 
formed cells again accumulated more [~4C]Cho compared to 
untransformed cells. At 200 nM concentration wortmannin 
slightly enhanced (maximum 1.5-fold) or slightly decreased 
(maximum by 19%) the [~4C]Cho content of untransformed and 
Ras-transformed fibroblasts, respectively. 
The rate of [t4C]fhoP formation was 20- to 24-fold greater 
in the Ras-transformed cells (Fig. 2D) compared to the un- 
transformed cells (Fig. 2C). Even 200 nM wortmannin failed 
to modify the formation of [14C]ChoP in the untransformed 
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Fig. 3. Effects of wortmannin on PMA-induced formation of [~4C]Etn 
and [~4C]EtnP from [14C]PtdEtn i  Ha-Ras-transformed fibroblasts. 
Ha-Ras-transformed fibroblasts were prelabeled with [~4C]Etn and then 
treated with wortmannin as described in section 2. Prelabeled fibro- 
blasts were incubated for 2 h in the absence (D) or presence of 200 nM 
wortmannin (e~), 100 nM PMA (m), or wortmannin plus PMA (I); the 
incubation medium also contained 50/~M (I) or 1 mM (II) unlabeled 
Etn. [~4C]Etn and [~4C]EtnP were determined asdescribed in section 2. 
Data are the mean + S.E. of six independent incubations. 
cells. Wortmannin also failed to decrease [14C]ChoP formation 
in the Ras-transformed cells during the first 90 min of treat- 
ment, but after treatments for 150 min it decreased [~4C]ChoP 
formation by 16 to 19% (Fig. 2D). 
Surprisingly, in untransformed fibroblasts wortmannin even 
at the lower (50 nM) concentration significantly inhibited the 
incorporation of [J4C]choline into PtdCho (Fig. 2E). Since 
wortmannin failed to inhibit [14C]ChoP formation in these cells, 
inhibition of PtdCho synthesis hould have occurred either at 
the level of cytidylyltransferase or at the final synthetic step. 
The effect of wortmannin on PtdCho synthesis was clearly 
different from that on EtnP formation and was not pursued 
further here. In the Ras-transformed cells (Fig. 2F) the rate of 
PtdCho labeling/synthesis was about 10 times greater than in 
the control cells (Fig. 2E). In the transformed cells, wortmannin 
had no significant effect on PtdCho synthesis up to 120 min, 
but it slightly (by 12-15%), although significantly, decreased the 
incorporation of [14C]Cho into PtdCho after 150 min incuba- 
tion (Fig. 2F). It should be added here that extension of incuba- 
tion period up to 6 h failed to increase the inhibitory effect of 
wortmannin on [laC]ChoP formation (data not shown). 
Etn and Cho are presumably phosphorylated by the same 
kinase activity [19], while transport of these precursors across 
the cell membrane involves different mechanisms [18]. There- 
fore, it was possible that wortmannin actually inhibited the 
uptake of [14C]Etn and this process was reflected in decreased 
formation of [14C]EtnP. However, due to the presence of an 
extremely active kinase activity in the transformed cells and to 
the absence of a specific kinase inhibitor, it is virtually impossi- 
ble to directly determine possible inhibition of [14C]Etn uptake 
by wortmannin. However, it is possible to endogenously gener- 
ate a large intracellular pool of [14C]Etn by PMA-induced, 
phospholipase D-mediated, hydrolysis of prelabeled PtdEtn. 
We have previously reported that transformation of NIH 3T3 
fibroblasts by Ha-Ras actually enhanced the effect of PMA on 
PtdEtn hydrolysis [20]. As shown in Fig. 3, at 50/~M concentra- 
tion of Etn in the medium PMA-treated [14C]Etn-prelabeled 
Ha-Ras-transformed fibroblasts generated significant amounts 
of both [~4C]Etn and [~4C]EtnP, while at 1 mM Etn PMA in- 
duced only [~4C]Etn formation. This indicates the 50/IM Etn 
only partially, while 1 mM Etn fully inhibited phosphorylation 
of [14C]Etn formed by PMA-induced hydrolysis of [14C]PtdEtn. 
Importantly, wortmannin (200 nM) inhibited neither the phos- 
phorylation of [~4C]Etn (at 50/.tM Etn) nor the formation of 
[~4C]Etn (at 1 mM Etn). These data clearly indicate that wort- 
mannin does not directly inhibit phosphorylation of Etn, and 
it is also without effect on phospholipase D activity. 
In summary, these results demonstrate for the first time that 
activated Ras greatly enhances the Etn-phosphorylating capac- 
ity of cells, along with the stimulation of ChoP formation. This 
is consistent with Etn and Cho being phosphorylated by the 
same kinase activity [19]. Clearly, Ha-Ras also stimulates the 
uptake of these precursors. The results indicating that wort- 
mannin inhibited only the phosphorylation f externally added 
Etn, but not of Etn formed endogenously from PtdEtn, strongly 
suggest hat PI3K, activated by mutated Ras [13], positively 
regulates Etn transport. Many human cancers are character- 
ized by increased levels of EtnP, but not ChoP [21-27]. This 
suggests that aggressive growth of certain cancers requires high 
levels of EtnP, which is achieved through the stimulation of 
both uptake and phosphorylation f Etn. The present findings, 
implicating both activated Ras and PI3K in the regulation of 
Etn metabolism, represent an important step toward determi- 
nation of the possible role of Etn/EtnP in human cancers. 
Acknowledgements: This study was supported by The Hormel Founda- 
tion. We are grateful to Ms. C. Perleberg for secretarial assistance. 
The University of Minnesota is an equal opportunity educator and 
employer. 
References 
[1] Grand, R.J.A. and Owen, D. (1991) Biochem. J. 279, 609-631. 
[2] Abdellatif, M., MacLellan, W.R. and Schneider, M.D. (1994) 
J. Biol. Chem. 269, 15423-15426. 
[3] Satoh, T., Nakafuku, M. and Kaziro, Y. (1992) J. Biol. Chem. 267, 
24149-24152. 
[4] Lowe, P.N. and Skinner, R.H. (1994) Cell. Signalling 6, 1099 
123. 
[5] Feig, L.A. and Schaffhansen, B. (1994) Nature 370, 508-509. 
[6] Macara, I.G. (1989) Mol. Cell Biol. 9, 325-328. 
[7] Cuadrado, A., Carnero, A., Dolfi, F., Jimenez, B. and Lacal, J.C. 
(1993) Oncogene 8, 2959-2968. 
[8] Kiss, Z., Crilly, K.S. and Anderson, W.H. (1993) FEBS Lett. 336, 
115-118. 
[9] Shilo, B.Z. and Weinberg, R.A. (1981) Nature 289, 607-609. 
[10] Chen, A.C. and Herschman, H.R. (1989) Proc. Natl. Acad. Sci. 
USA 86, 1608-1611. 
[11] Smith, G.J. and Grisham, J.W. (1987) Biochem. Biophys. Res. 
Commun. 147, 1194-1199. 
[12] Balmain, A., Ramsden, M., Bowden, G.T. and Smith, J. (1984), 
Nature 307, 658~560. 
[13] Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesebroeck, 
B., Gout, I., Fry, M.J., Waterfield, M.D. and Downward, J. (1994) 
Nature 370, 527-532. 
[14] Arcano, A. and Wymann, M.P. (1993) Biochem. J 296, 297-301. 
[15] Chang, E.H., Maryak, J.M., Wei, C.M., Shih, T.Y., Shober, R., 
Cheung, H.L., Ellis, R.W., Hager, G.L., Scolnick, E.M. and Lowy, 
D.R. (1980) J. Virol. 35, 76-82. 
[16] Cook, S.J. and Wakelam, M.J.O. (1991) Biochim. Biophys. Acta 
1092, 265-272. 
[17] Kiss, Z. and Anderson, W.B. (1990) J. Biol. Chem. 265, 7345- 
7350. 
[18] Lipton, B.A., Davidson, E.P., Ginsberg, B.H. and Yorek, M.A. 
(1990) J. Biol. Chem. 265, 7195-7201. 
[19] Porter, T.J. and Kent, C. (1990) J. Biol. Chem. 265, 414-422. 
[20] Kiss, Z., Rapp, U.R., Pettit, G.R. and Anderson, W.B. (1991) 
Biochem. J. 276, 505-509. 
282 Z. Kiss, K.S. CrilIy/FEBS Letters 357 (1995) 279-282 
[21] Navon, G., Navon, R., Shulman, R.G. and Yamane, T. (1978) 
Proc. Natl. Acad. Sci. USA 75, 891-895. 
[22] Evanochko, W.T., Sakai, T.T., Ng, T.C., Krishna, N.R., Kim, 
H.D., Zeidler, R.B., Ghanta, V.K., Brockman, R.W., Schiffer, 
L.M., Braunschweiger, P.G. and Glickson, J.D. (1984) Biochim. 
Biophys. Acta 805, 1014~1016. 
[23] Ronen, S.M., Stier, A. and Degani, H. (1990) FEBS Lett. 226, 
147-149. 
[24] Cadoux-Hudson, T.A.D., Blackledge, M.J., Rajagopalan, B., 
Taylor, D.J. and Radda, G.K. (1989) Br. J. Cancer 60, 430436. 
[25] Kalra, R., Wade, K.E., Hands, L., Styles, P., Camplejohn, R., 
Greenall, M., Adams, G.E., Harris, A.L. and Radda, G.K. (1993) 
Br. J. Cancer 67, 1145 1153. 
[26] Merchant, T.G., Gierke, L.W., Meneses, P. and Glonek, T. (1988) 
Cancer Res. 48, 5112-5118. 
[27] Dixon, R.M., Angus, P.W., Rajagopalan, B. and Radda, G.K. 
(1991) Br. J. Cancer 63,953-958. 
